Title not supplied

AUTHOR UNKNOWN

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Rowley JD

Nature, (5405):290-293 1973

MED: 4126434

Chronic myelogenous leukemia: mechanisms underlying disease progression.

Shet AS, Jahagirdar BN, Verfaillie CM

Leukemia, (8):1402-1411 2002

MED: 12145676

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.

Hughes TP, Kaeda J, Branford S, Rudzki Z, Hochhaus A, Hensley ML, Gathmann I, Bolton AE, van Hoomissen IC, Goldman JM, Radich JP; International Randomised Study of Interferon versus STI571 (IRIS) Study Group

N Engl J Med, (15):1423-1432 2003

MED: 14534335

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.

Hochhaus A, O'Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L, Goldman JM, Muller MC, Radich JP, Rudoltz M, Mone M, Gathmann I, Hughes TP, Larson RA; IRIS Investigators, Hughes T, Taylor K, Durant S, Schwarer A, Joske D, Seymour J, Grigg A, Ma D, Arthur C, Bradstock K, Joshua D, Agis H, Verhoef G, Louwagie A, Martiat P, Bosly A, Shepherd J, Shistok C, Lipton J, Forrest D, Walker I, Roy DC, Rubinger M, Bence-Bruckler I, Stewart D, Kovacs M, Turner AR, Nielsen J, Birgens H, Bjerrum O, Rousselot P, Reiffers J, Facon T, Harousseau JL, Tulliez M, Guerci A, Blaise D, Maloisel F, Michallet M, Fischer T, Hochhaus A, Andreesen R, Nerl C, Freund M, Gattermann N, Ehninger G, Niederwieser D, Ottmann OG, Peschel C, Ho AD, Neubauer A, le Coutre P, Aulitzky W, Saglio G, Baccarani M, Fanin R, Rosti G, Mandelli F, Lazzarino M, Morra E, Carella A, Petrini M, Nobile F, Liso V, Ferrara F, Rizzoli V, Fiortoni G, Martinelli G, Cornelissen J, Ossenkoppele G, Browett P, Gedde-Dahl T, Tangen JM, Dahl I, Cervantes F, Odrizoala J, Hernandez Boulda JC, Steegmann JL, Canizo C, Diaz J, Grenena A, Fernandez M, Simonsson B, Stenke L, Paul C, Bjoreman M, Malm C, Wadenvik H, Nilsson PG, Turesson I, Gratwohl A, Hess U, Solenthaler M, Goldman JM, Clark RE, Green A, Holyoake T, Lucas G, Smith G, Milligan D, Rule S, Burnett A, Kantarjian H, Silver R, Stone R, Powell B, Gabrilove J, Moroose R, Wetzler M, Bearden J, Cataland S, Rabinowitz I, Meisenberg B, Thompson K, Graziano S, Emanuel P, Gross H, Cobb P, Bhatia R, Dakhil S, Irwin AD, Issell B, Pavletic S, Kuebler P, Layhe E, Butra P, Glass J, Moore J, Grant B, Neill H, Herzig R, Burris H, Petersen B, Kalaycio M, Stirewalt D, Samlowski W, Berman E, Limentani S, Seay T, Shea T, Akard L, Smith G, Becker P, Devine S, Hart R, Veith R, Wade J, Brunvad M, Kalman L, Strickland D, Shurafa M, Bashey A, Shadduck R, Safah H, Rubenstein M, Collins R, Keller A, Tallman M, Pecora A, Agha M, Homes H, Guidice R, Druker BJ, Guilhot F, Larson RA, O'Brien S, Rowe J, Schiffer CA, Buyse M, Baccarani M, Cervantes F, Cornelissen J, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Reiffers J, Rousselot P, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Talpaz M, Taylor K, Verhoef G, Santini V

Leukemia, (6):1054-1061 2009

MED: 19282833

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M

N Engl J Med, (14):1038-1042 2001

MED: 11287973

Imatinib resistance in CML.

Volpe G, Panuzzo C, Ulisciani S, Cilloni D

Cancer Lett, (1):1-9 2008

MED: 18653275

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

Johansson B, Fioretos T, Mitelman F

Acta Haematol, (2):76-94 2002

MED: 11919388

Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.

Boultwood J, Peniket A, Watkins F, Shepherd P, McGale P, Richards S, Fidler C, Littlewood TJ, Wainscoat JS

Blood, (1):358-361 2000

MED: 10891474

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.

Campbell LJ, Fidler C, Eagleton H, Peniket A, Kusec R, Gal S, Littlewood TJ, Wainscoat JS, Boultwood J

Leukemia, (4):671-679 2006

MED: 16498395